Aligos Therapeutics vs Hepion Pharmaceuticals

Aligos Therapeutics

Improving patient outcomes through best-in-class therapies for liver and viral diseases

97 employees · est. 2018 · South San Francisco, United...

Hepion Pharmaceuticals

Hepion Pharmaceuticals, Inc. is not affiliated in any way with Wire™ or Wire Swiss GmbH in any capacity

7 employees · est. 2013 · Edison, United States

Hepion Pharmaceuticals is the older company (2018 vs 2013); Aligos Therapeutics is the larger of the two.

Side-by-Side Comparison

Metric	Aligos Therapeutics	Hepion Pharmaceuticals
Founded
Founded	2018	2013 older
Headquarters
Headquarters	South San Francisco, United States	Edison, United States
Employees
Employees	97 larger	7
Industry
Industry	Biotechnology	Biotechnology, Life Sciences, Pharmaceutical
Funding Stage
Funding Stage	Not tracked yet	Post-IPO Debt
Total Funding
Total Funding	$505.60M	$134.82M
Funding Rounds
Funding Rounds	7	10
Taxonomy
Taxonomy	Biopharmaceutical CompanyTherapeuticsLiver DiseasesViral InfectionsClinical StageAntiviral Therapies +9	BiopharmaceuticalLiver DiseaseNASHChronic HepatitisCirrhosisMedication Therapies +8
Website
Website	aligos.com	hepionpharma.com

About Aligos Therapeutics

Aligos Therapeutics is a biopharmaceutical company founded in 2018 and headquartered in the United States. The company is focused on developing targeted therapeutics to address unmet medical needs in liver and viral diseases, including nonalcoholic steatohepatitis (MASH), chronic hepatitis B (CHB),...

View Full Profile Alternatives

About Hepion Pharmaceuticals

Hepion Pharmaceuticals is a biopharmaceutical company established in 2013 and headquartered in the United States. The company is publicly traded on Nasdaq (HEPA) and focuses on developing a pleiotropic drug therapy for chronic liver diseases, specifically targeting fibrosis and hepatocellular carcin...

View Full Profile

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Aligos Therapeutics and Hepion Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Aligos Therapeutics or Hepion Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Frequently Asked Questions

Aligos Therapeutics was founded in 2018, based in South San Francisco, United States, with 97 employees. Aligos Therapeutics is a biopharmaceutical company founded in 2018 and headquartered in the United States. The company is focused on developing targeted therapeutics to address unmet medical needs in. Hepion Pharmaceuticals was founded in 2013, based in Edison, United States, with 7 employees. Hepion Pharmaceuticals is a biopharmaceutical company established in 2013 and headquartered in the United States. The company is publicly traded on Nasdaq (HEPA) and focuses on developing a pleiotropi.

Aligos Therapeutics has raised $505.60M and Hepion Pharmaceuticals $134.82M. Latest stage: Hepion Pharmaceuticals Post-IPO Debt.

Both work in Biotechnology and list drug development, nash and viral hepatitis among their focus areas.

Compare Aligos Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Aligos Therapeutics Alternatives All Companies All Signals

Compiled from the BounceWatch company index. We last looked at Aligos Therapeutics on 9 Jun 2026, and Hepion Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.